Oscar Health, Inc. (NYSE:OSCR - Get Free Report)'s share price crossed below its 50-day moving average during trading on Thursday. The stock has a 50-day moving average of $32.00 and traded as low as $30.60. Oscar Health shares last traded at $31.8060, with a volume of 3,659,010 shares traded.
Wall Street Analysts Forecast Growth
Several research analysts recently weighed in on OSCR shares. Weiss Ratings raised shares of Oscar Health from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Thursday, October 8th. Bank of America raised their price target on shares of Oscar Health from $28.00 to $30.00 and gave the stock an "underperform" rating in a research note on Thursday, September 17th. Stephens reiterated an "equal weight" rating and set a $34.00 price target on shares of Oscar Health in a report on Thursday, September 17th. Raymond James Financial upped their price objective on shares of Oscar Health from $34.00 to $42.00 and gave the company an "outperform" rating in a research note on Friday, September 18th. Finally, Barclays upped their price objective on shares of Oscar Health from $39.00 to $49.00 and gave the company an "overweight" rating in a research note on Thursday, September 17th. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Oscar Health presently has an average rating of "Hold" and a consensus price target of $34.60.
Check Out Our Latest Analysis on Oscar Health
Oscar Health Price Performance
The company has a 50-day moving average of $32.00 and a two-hundred day moving average of $24.30. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.16 and a quick ratio of 1.16. The stock has a market capitalization of $9.82 billion, a PE ratio of 13.14, a P/E/G ratio of 0.24 and a beta of 2.56.
Oscar Health (NYSE:OSCR - Get Free Report) last released its earnings results on Thursday, November 5th. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.14) by $0.63. Oscar Health had a net margin of 4.90% and a return on equity of 49.39%. The business had revenue of $5.14 billion for the quarter, compared to analysts' expectations of $4.69 billion. During the same period last year, the company earned ($0.53) earnings per share. The company's quarterly revenue was up 72.1% on a year-over-year basis. Sell-side analysts predict that Oscar Health, Inc. will post 2.48 EPS for the current fiscal year.
Insider Activity at Oscar Health
In other news, CAO Victoria Baltrus sold 958 shares of the company's stock in a transaction on Thursday, September 3rd. The stock was sold at an average price of $31.45, for a total transaction of $30,129.10. Following the completion of the sale, the chief accounting officer directly owned 213,631 shares in the company, valued at $6,718,694.95. This represents a 0.45% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Vanessa Wittman sold 25,000 shares of the stock in a transaction on Friday, September 18th. The stock was sold at an average price of $32.24, for a total value of $806,000.00. Following the completion of the transaction, the director directly owned 112,121 shares in the company, valued at $3,614,781.04. This trade represents a 18.23% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 874,451 shares of company stock worth $26,761,671. 22.64% of the stock is owned by corporate insiders.
Institutional Trading of Oscar Health
A number of institutional investors and hedge funds have recently bought and sold shares of the business. Bank of America Corp DE lifted its position in Oscar Health by 205.1% during the first quarter. Bank of America Corp DE now owns 2,860,310 shares of the company's stock valued at $32,808,000 after buying an additional 1,922,732 shares in the last quarter. Assenagon Asset Management S.A. increased its position in shares of Oscar Health by 107.5% in the third quarter. Assenagon Asset Management S.A. now owns 2,589,708 shares of the company's stock worth $79,867,000 after acquiring an additional 1,341,716 shares in the last quarter. Wedge Capital Management L L P NC purchased a new position in shares of Oscar Health in the 2nd quarter valued at $32,855,000. Dimensional Fund Advisors LP boosted its position in Oscar Health by 22.1% during the 1st quarter. Dimensional Fund Advisors LP now owns 4,192,777 shares of the company's stock worth $48,078,000 after purchasing an additional 759,837 shares during the period. Finally, Halter Ferguson Financial Inc. boosted its position in Oscar Health by 93.3% during the 3rd quarter. Halter Ferguson Financial Inc. now owns 1,211,825 shares of the company's stock worth $37,373,000 after purchasing an additional 584,818 shares during the period. Institutional investors and hedge funds own 75.70% of the company's stock.
About Oscar Health
(
Get Free Report)
Oscar Health is a U.S. health insurance company that uses technology and digital tools to connect members with health coverage and care. Founded in 2012, the company initially focused on individual health plans and has expanded its offerings to include coverage for small businesses. Oscar's products include individual and family plans, generally offered through the Affordable Care Act marketplaces, as well as small-group health insurance. Its services include a mobile app and online tools for managing benefits, finding care, and communicating with care teams.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.